Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term administration & dosage. Found 208 abstracts

no pagination
Guo P, Ma J, Li S, Guo Z, Adams AL, Gallo JM. Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model. Cancer Chemother Pharmacol. 2001 Aug;48(2):169-76.
Guttormsen AB, Ueland PM, Kruger WD, Kim CE, Ose L, Folling I, Refsum H. Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype. Am J Med Genet. 2001 May;100(3):204-13.
Haas NB. Can chemotherapy alter the course of prostate cancer?. Semin Urol Oncol. 2001 Aug;19(3):212-21.
Haas N, Roth B, Garay C, Yeslow G, Entmacher M, Weinstein A, Rogatko A, Babb J, Minnitti C, Flinker D, Gillon T, Hudes G. Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer. Urology. 2001 Jul;58(1):59-64.
Hartman TJ, Dorgan JF, Woodson K, Virtamo J, Tangrea JA, Heinonen OP, Taylor PR, Barrett MJ, Albanes D. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. The Prostate. 2001 Jan;46(1):33-8.
Huang CH, Treat J. New advances in lung cancer chemotherapy: topotecan and the role of topoisomerase I inhibitors. Oncology. 2001 Jan;61 Suppl 1:14-24.
Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. Clin Cancer Res. 2001 Jan;7(1):68-73.
Langer CJ. The emerging world role of irinotecan in lung cancer. Oncology (Huntingt). 2001 Jul;15(7 Suppl 8):15-21.
Langer CJ. The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer. Lung Cancer. 2001 Nov;34(2):297-303.
Langer CJ, Ruffer J, Rhodes H, Paulus R, Murray K, Movsas B, Curran W. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2001 Sep;51(1):113-9.
Levy MH. Advancement of opioid analgesia with controlled-release oxycodone. Eur J Pain. 2001 Jan;5 Suppl A:113-6.
Meropol NJ, Niedzwiecki D, Hollis D, Schilsky RL, Mayer RJ. Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma. Cancer. 2001 Apr;91(7):1256-63.
Obarzanek E, Kimm SY, Barton BA, Van Horn LL, Kwiterovich PO, Simons-Morton DG, Hunsberger SA, Lasser NL, Robson AM, Franklin FA, Lauer RM, Stevens VJ, Friedman LA, Dorgan JF, Greenlick MR. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC). Pediatrics. 2001 Feb;107(2):256-64.
Obasaju C, Hudes GR. Paclitaxel and docetaxel in prostate cancer. Hematol Oncol Clin North Am. 2001 Jun;15(3):525-45.
O'Dwyer PJ, Manola J, Valone FH, Ryan LM, Hines JD, Wadler S, Haller DG, Arbuck SG, Weiner LM, Mayer RJ, Benson AB. Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study. J Clin Oncol. 2001 May;19(9):2413-21.
Ozols RF. The current role of gemcitabine in ovarian cancer. Semin Oncol. 2001 Apr;28(2 Suppl 7):18-24.
Pandya KJ, Yeap BY, Weiner LM, Krook JE, Erban JK, Schinella RA, Davis TE. Megestrol and tamoxifen in patients with advanced endometrial cancer: an Eastern Cooperative Oncology Group Study (E4882). Am J Clin Oncol. 2001 Feb;24(1):43-6.
Ranganathan S, McCauley RA, Dexter DW, Hudes GR. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Br J Cancer. 2001 Sep;85(5):735-40.
Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol. 2001 Sep 15;19(18):3801-7.
Sasson AR, Watson JC, Sigurdson ER. Hepatic artery infusional chemotherapy for colorectal liver metastases. Cancer Treat Res. 2001 Jan;109:279-98.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term administration & dosage

administration & dosage Human drug therapy Male Antineoplastic Combined Chemotherapy Protocols therapeutic use Female Middle Age Aged analogs & derivatives Paclitaxel Treatment Outcome US Gov't Support-PHS pathology Prostatic Neoplasms adverse effects Non-US Gov't Support adverse Antineoplastic Agents Estramustine Oral Administration effects Leucovorin Fluorouracil Lung Neoplasms Clinical Trials Non-Small-Cell Lung Carcinoma Adult Survival Analysis pharmacology genetics blood drug effects Enzyme Inhibitors Colorectal Neoplasms Phytogenic Antineoplastic Agents derivatives analogs & metabolism mortality Neoplasm Drug Resistance Camptothecin Disease Progression Adenocarcinoma 80 and over Aged Drug Administration Schedule Drug Dose-Response Relationship secondary Neoplasm Proteins Follow-Up Studies Antineoplastic Antimetabolites Microtubules Cholesterol Prognosis Adolescent Intravenous Infusions Cultured Tumor Cells Tubulin Uracil therapy Cisplatin administration & antagonists & inhibitors Deoxycytidine radiotherapy dosage analysis Adjuvant Chemotherapy Mitoxantrone Neoplasm Staging chemically induced Drug Delivery Systems Prolactin Antisense Oligodeoxyribonucleotides Hydrocortisone Oxidoreductases Body Height Delayed-Action Preparations secretion Local Neoplasm Recurrence Carcinoma Nude Rats use Proportional Hazards Models Liver Neoplasms Gastrointestinal Diseases Pain deficiency Genetic Vectors Ferritin Proto-Oncogene Proteins c-bcl-2 Interferon Alfa-2a Palliative Care Sprague-Dawley Rats Reverse Transcriptase Polymerase Chain Reaction etiology Edema Intra-Arterial Infusions diet therapy Protein Isoforms therapeutic Feasibility Studies Brain Neoplasms physiopathology Randomized Controlled Trials Japan Colchicine Nutritional Status Fat-Restricted Diet Triglycerides Testosterone Drug Combinations Hypercholesterolemia United States Phosphonoacetic Acid Mortality Homocysteine Tegafur DNA Oxycodone Body Mass Index Syndrome Transfection bcl-2 Genes diagnosis Isoquinolines Carboplatin Vinblastine Heterozygote urine enzymology Quality of Life Linear Models Radioimmunoassay ultrastructure Risk Factors Aspartic Acid Reference Values Phase I Clinical Trials Dietary Fats Drug Synergism Anaphylaxis pharmacokinetics Disease-Free Survival Liver Diseases Homocystinuria Signal Transduction Etoposide Type I DNA Topoisomerases Cystathionine
Last updated on Saturday, August 08, 2020